Predictive Factors for the Development of Capecitabine-Induced Hand-Foot Syndrome

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20230902001

Enrollment

205

Registered

2023-09-02

Start date

2019-01-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Capecitabine-induced hand-foot syndrome (HFS) is a common condition that significantly affects patients&#039

Interventions

patients treated with capecitabine

Prevention

capecitabine group

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Data of patients treated with capecitabine.

Exclusion criteria

Exclusion criteria: insufficient data

Design outcomes

Primary

Measure	Time frame
Capecitabine-induced hand-foot syndrome (HFS) 6 month grade of HFS	—

Secondary

Measure	Time frame
prognostic factors 6 month HFS grade 2-3	—

Countries

Thailand

Contacts

Public ContactChaichana Chantharakhit

Buddhasothorn Hospital

chaichana.md@gmail.com0817866945

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026